Page last updated: 2024-10-27

fluorouracil and Diffuse Parenchymal Lung Disease

fluorouracil has been researched along with Diffuse Parenchymal Lung Disease in 32 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Previously we reported combined chemo-immunotherapy, using interferon (IFN)-alpha and 5-fluorouracil (5-FU) for patients with advanced hepatocellular carcinoma (HCC), and this regimen improved the prognosis."7.72Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma. ( Aozasa, K; Dono, K; Hoshida, Y; Iizuka, N; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Tomita, Y; Umeshita, K; Yamamoto, S, 2004)
", folinic acid (FOL), fluorouracil (F) and oxaliplatin (OX), is a drug cocktail that is used to treat gastric and colorectal cancers."4.95Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient. ( De Weerdt, A; Dendooven, A; Jorens, PG; Lammens, M; Pen, J; Snoeckx, A, 2017)
"Pulmonary fibrosis is a rare complication of oxaliplatin and capecitabine/5-fluorouracil."4.87Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literature. ( Chan, AK; Choo, BA; Glaholm, J, 2011)
"Structural changes were found in the experimental (5-fluorouracil) group compared to the controls, including abnormal alveolar duct, sac, and terminal bronchioles with emphysematous changes in most of the alveoli in addition to peribronchiolitis, perivasculitis, inflammatory cells infiltration and interstitial fibrosis."3.80The structural changes of the rat's lung induced by intraperitoneal injection of 5-fluorouracil. ( Al-Hamdany, MZ; Al-Hubaity, AY, 2014)
"Oxaliplatin with 5-fluorouracil plus leucovorin (FOLFOX) has become the standard treatment in patients with colorectal cancer."3.76[Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin]. ( Jung, JJ; Kim, GB; Ko, JE; Ko, SH; Lee, YS; Park, S; Yoon, HS, 2010)
"Previously we reported combined chemo-immunotherapy, using interferon (IFN)-alpha and 5-fluorouracil (5-FU) for patients with advanced hepatocellular carcinoma (HCC), and this regimen improved the prognosis."3.72Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma. ( Aozasa, K; Dono, K; Hoshida, Y; Iizuka, N; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Tomita, Y; Umeshita, K; Yamamoto, S, 2004)
"Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall survival than gemcitabine therapy."2.87FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. ( Artru, P; Assenat, E; Bachet, JB; Ben Abdelghani, M; Biagi, JJ; Bouhier-Leporrier, K; Breysacher, G; Castan, F; Choné, L; Conroy, T; Cripps, C; Di Fiore, F; Faroux, R; Francois, E; Gourgou, S; Hammel, P; Hebbar, M; Jouffroy-Zeller, C; Juzyna, B; Kavan, P; Khemissa-Akouz, F; Lecomte, T; Legoux, JL; Malka, D; O'Callaghan, CJ; Raoul, JL; Rat, P; Sauvanet, A; Texereau, P; Volet, J; Wei, AC; Ychou, M, 2018)
"He was diagnosed with interstitial pneumonitis induced by irinotecan or panitumumab."2.48[A case of irinotecan or panitumumab-induced interstitial pneumonia successfully treated by steroid pulse therapy]. ( Abe, T; Ando, M; Kato, T; Nakashima, H; Shindo, J; Shiraki, A; Yamamoto, K; Yukita, Y, 2012)
"He was diagnosed with interstitial pneumonitis."2.47[A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)]. ( Fukushima, M; Hamada, A; Ishizaka, T; Mukai, J; Nakagawa, M; Sawada, R; Takahashi, N; Yoshihara, Y, 2011)
" Treatment was started with 30 mg of prednisolone, and the dosage was gradually decreased."1.72[A Case of Unilateral Interstitial Lung Disease in a Patient Treated with Oxaliplatin, 5-Fluorouracil, and Leucovorin]. ( Aisaki, K; Aoki, K; Doumoto, Y; Funatsu, K; Hosaka, M; Kimura, T; Kobori, S; Minoshima, K; Ushiku, H; Wakabayashi, M; Yoshida, H, 2022)
"It is used to treat metastatic colorectal carcinoma."1.62A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum. ( Ates, UC; Comert, B; Ergun, B; Gezer, S; Ugur, L; Yakar, N, 2021)
"Chemotherapy-induced interstitial lung disease in colorectal cancer patients is rare but represents a life-threatening adverse reaction."1.48Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report. ( Aizawa, K; Furukawa, T; Kozakai, H; Mitsuboshi, S; Nagai, K; Yamada, H, 2018)
"Interstitial lung disease in patients with colorectal cancer during chemotherapy combined with bevacizumab is rare."1.37Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients. ( Furushima, K; Ishihara, T; Katou, Y; Tanai, C; Tanaka, Y; Usui, K, 2011)
"Chemotherapy-induced interstitial lung disease (ILD) in colorectal cancer (CRC) patients is rarely reported, but its clinical features remain to be clarified."1.36Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer. ( Doi, T; Fuse, N; Joh, T; Minashi, K; Ohtsu, A; Shimura, T; Tahara, M; Yoshino, T, 2010)
"We report a case of acute interstitial pneumonitis and respiratory failure occurring in a 69-year-old, previously healthy patient receiving FOLFOX regimen plus cetuximab for colon cancer."1.36Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy. ( Chang, SC; Lai, JI; Lai, YC; Lin, PC; Wang, WS, 2010)
"Interstitial pneumonia was suspected, and we started treatment with steroid medication, but this had no effect."1.35[A case of diffusely infiltrating rectal cancer with pulmonary lymphangitis carcinomatosa successfully treated with mFOLFOX6 chemotherapy as salvage]. ( Fujita, M; Ishikawa, M; Katano, K; Mizuno, A; Okada, Y; Yamagishi, Y, 2008)
"Two fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis are reported here."1.35Fatal pneumonitis induced by oxaliplatin. ( Arévalo Lobera, S; Azkue Gabilondo, M; Basterretxea Badiola, L; Egaña Otaño, L; Elejoste Echeberría, I; La Casta Muñoa, A; Melé Olivé, M; Sagastibeltza Mariñelarena, N, 2008)
"We report here two cases of interstitial lung disease occurring in association with the use of this combination chemotherapy."1.35[Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)]. ( Kato, S; Miyate, Y; Ogasawara, N; Ohori, H; Suzuki, M; Takahashi, M, 2009)
"Once interstitial pneumonia has occurred, cessation of the regimen is mandatory, and high-dose corticosteroid treatment is commonly given to rescue patients from this potentially lethal complication."1.35Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX). ( Hatakeyama, K; Muneoka, K; Sakata, J; Sasaki, M; Shirai, Y; Wakai, T, 2009)
"Drug-induced interstitial pneumonitis was suspected, and Pneumocystis carini pneumonia was considered in the differential diagnosis."1.35[A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer]. ( Baba, N; Ishigami, S; Kitaguchi, K; Nakauchi, M; Nakayama, Y; Ohe, H; Sakikubo, M; Taira, K; Tamura, J; Ura, K; Yoshikawa, A, 2009)
"Progressive respiratory failure developed in a 68 year-old female who was treated with single-agent oxaliplatin for colorectal cancer."1.33Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer. ( Colomer, R; Fabregat, MB; Merino, BQ; Puig, J; Soy, E; Yagüe, XH, 2005)

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (37.50)29.6817
2010's17 (53.13)24.3611
2020's3 (9.38)2.80

Authors

AuthorsStudies
Kimura, T1
Wakabayashi, M1
Kobori, S1
Aoki, K1
Yoshida, H1
Minoshima, K1
Doumoto, Y1
Hosaka, M1
Ushiku, H1
Aisaki, K1
Funatsu, K1
El-Hout, S1
Lopez, L1
Schaeverbeke, T1
Richez, C1
Kostine, M1
Truchetet, ME1
Yakar, N1
Ergun, B1
Ugur, L1
Ates, UC1
Gezer, S1
Comert, B1
Mitsuboshi, S1
Kozakai, H1
Yamada, H1
Nagai, K1
Furukawa, T1
Aizawa, K1
De Weerdt, A1
Dendooven, A1
Snoeckx, A1
Pen, J1
Lammens, M1
Jorens, PG1
Aoyagi, H1
Ito, H1
Higuchi, K1
Koseki, K1
Watanabe, I1
Tanaka, Y2
Suzuki, K1
Nishi, N1
Nihei, Z1
Ito, M1
Conroy, T1
Hammel, P1
Hebbar, M1
Ben Abdelghani, M1
Wei, AC1
Raoul, JL2
Choné, L1
Francois, E1
Artru, P1
Biagi, JJ1
Lecomte, T1
Assenat, E1
Faroux, R1
Ychou, M1
Volet, J1
Sauvanet, A1
Breysacher, G1
Di Fiore, F1
Cripps, C1
Kavan, P1
Texereau, P1
Bouhier-Leporrier, K1
Khemissa-Akouz, F1
Legoux, JL1
Juzyna, B1
Gourgou, S1
O'Callaghan, CJ1
Jouffroy-Zeller, C1
Rat, P1
Malka, D1
Castan, F1
Bachet, JB1
Rezkallah, KNM1
Ahmed, A1
Patel, S1
Kozma, K1
Tamura, S1
Kusaba, H1
Kubo, N1
Ijichi, K1
Tsuchihashi, K1
Komoda, M1
Uchino, K1
Ariyama, H1
Akashi, K1
Baba, E1
Al-Hamdany, MZ1
Al-Hubaity, AY1
Vargas, A1
Montironi, C1
Buxó, E1
Sánchez Cendra, C1
Juez Martel, I1
Gutierrez Abad, D1
Yamagishi, Y1
Okada, Y1
Ishikawa, M1
Mizuno, A1
Katano, K1
Fujita, M1
Arévalo Lobera, S1
Sagastibeltza Mariñelarena, N1
Elejoste Echeberría, I1
Melé Olivé, M1
Egaña Otaño, L1
Basterretxea Badiola, L1
La Casta Muñoa, A1
Azkue Gabilondo, M1
Ohori, H1
Takahashi, M1
Ogasawara, N1
Suzuki, M1
Miyate, Y1
Kato, S1
Pena Alvarez, C1
Suh Oh, HJ1
Sáenz de Miera Rodríguez, A1
García Arroyo, FR1
Covela Rúa, M1
Salgado Boquete, L1
López Clemente, PM1
Constenla Figueiras, M1
Muneoka, K1
Shirai, Y1
Sasaki, M1
Wakai, T1
Sakata, J1
Hatakeyama, K1
Tamura, J1
Nakauchi, M1
Nakayama, Y1
Kitaguchi, K1
Sakikubo, M1
Ura, K1
Taira, K1
Ohe, H1
Yoshikawa, A1
Ishigami, S1
Baba, N1
Shimura, T1
Fuse, N1
Yoshino, T1
Minashi, K1
Tahara, M1
Doi, T1
Joh, T1
Ohtsu, A1
Lai, JI1
Wang, WS1
Lai, YC1
Lin, PC1
Chang, SC1
Park, S1
Jung, JJ1
Kim, GB1
Yoon, HS1
Ko, SH1
Ko, JE1
Lee, YS1
Usui, K1
Katou, Y1
Furushima, K1
Tanai, C1
Ishihara, T1
Nakagawa, M1
Hamada, A1
Yoshihara, Y1
Ishizaka, T1
Fukushima, M1
Takahashi, N1
Sawada, R1
Mukai, J1
Chan, AK1
Choo, BA1
Glaholm, J1
Yamamoto, K1
Kato, T2
Shindo, J1
Ando, M1
Abe, T1
Shiraki, A1
Nakashima, H1
Yukita, Y1
Shioiri, M1
Hasegawa, M1
Tanaka, H1
Toura, I1
Kudo, S1
Sato, K1
Inoue, K1
Nakanishi, T1
Nishiyama, S1
Takebe, S1
Ogino, Y1
Ohsaki, S1
Nagashima, Y1
Yamamoto, S2
Tomita, Y1
Hoshida, Y1
Iizuka, N1
Marubashi, S1
Miyamoto, A1
Nagano, H1
Dono, K1
Umeshita, K1
Nakamori, S1
Sakon, M1
Aozasa, K1
Monden, M1
Nishimoto, T1
Kiriyama, K1
Yabu, M1
Himeno, S1
Yagüe, XH1
Soy, E1
Merino, BQ1
Puig, J1
Fabregat, MB1
Colomer, R1
Ruiz-Casado, A1
García, MD1
Racionero, MA1
Jung, KH1
Kil, SY1
Choi, IK1
Seo, JH1
Shin, C1
Kim, YS1
Kim, JH1
Egreteau, J1
Boucher, E1
Lesimple, T1
Le Prisé, E1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Therapeutic Efficacy and Safety of Concurrent FOLFIRINOX Plus HIFU for Locally Advanced/Borderline Resectable Pancreatic Cancer: A Prospective Single-center, Single-arm, Investigator-initiated, Open-labeled, Exploratory Clinical Trial[NCT05262452]60 participants (Anticipated)Interventional2021-08-09Recruiting
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. A Pan-European Prospective Multicenter Double Single Arm Cohort Study.[NCT06068023]400 participants (Anticipated)Observational2023-07-01Recruiting
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) Functional CTCs Using EPIDROP[NCT05346536]63 participants (Anticipated)Interventional2022-06-16Recruiting
The Outcome After Operation for Pancreatic and Periampullary Tumors in Greeland Inuit.[NCT05595811]2,326 participants (Actual)Observational1999-01-01Completed
Postoperative and Long-term Survival in Relation to Life-expectancy After Pancreatic Surgery in Elderly Patients[NCT04893408]1,556 participants (Actual)Observational2010-01-01Completed
Multicentric Randomized Phase III Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma[NCT01526135]Phase 3493 participants (Actual)Interventional2012-04-16Completed
Phase II Study of Neoadjuvant Folfirinox Chemotherapy Followed by Pembrolizumab Followed by Surgery for Patients With Localized, Resectable Adenocarcinoma of the Pancreas[NCT05132504]Phase 230 participants (Anticipated)Interventional2022-08-31Recruiting
Phase II Study to Assess the Interest of a Sequential Treatment With Gemcitabine/Nab-paclitaxel (GEMBRAX) and Then FOLFIRINOX Followed by Stereotactic Magnetic Resonance-guided Adaptive Radiotherapy in Patients With Locally Advanced Pancreatic Cancer[NCT04570943]Phase 2103 participants (Anticipated)Interventional2020-12-15Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for fluorouracil and Diffuse Parenchymal Lung Disease

ArticleYear
Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.
    BMC cancer, 2017, Aug-29, Volume: 17, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms;

2017
[A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Leucovorin; Lung Disease

2011
Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literature.
    Onkologie, 2011, Volume: 34, Issue:8-9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectom

2011
[A case of irinotecan or panitumumab-induced interstitial pneumonia successfully treated by steroid pulse therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:2

    Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neopla

2012

Trials

1 trial available for fluorouracil and Diffuse Parenchymal Lung Disease

ArticleYear
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    The New England journal of medicine, 2018, 12-20, Volume: 379, Issue:25

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018

Other Studies

27 other studies available for fluorouracil and Diffuse Parenchymal Lung Disease

ArticleYear
[A Case of Unilateral Interstitial Lung Disease in a Patient Treated with Oxaliplatin, 5-Fluorouracil, and Leucovorin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Le

2022
Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reports.
    Rheumatology (Oxford, England), 2021, 02-01, Volume: 60, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Hu

2021
A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Leucovor

2021
Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2018, Volume: 24, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasm

2018
[A Case of Fatal Interstitial Pneumonia during FOLFIRI plus Cetuximab Therapy for Liver Metastasis of Colon Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Fatal Outcome; Female

2018
A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome.
    BMJ case reports, 2019, Feb-09, Volume: 12, Issue:2

    Topics: Adenocarcinoma; Adrenal Cortex Hormones; Aged, 80 and over; Antineoplastic Agents, Immunological; An

2019
Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer.
    Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Ch

2014
The structural changes of the rat's lung induced by intraperitoneal injection of 5-fluorouracil.
    JPMA. The Journal of the Pakistan Medical Association, 2014, Volume: 64, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Case-Control Studies; Female; Fibrosis; Fluorouracil; Inje

2014
Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:11

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Coloni

2015
Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.
    Archivos de bronconeumologia, 2017, Volume: 53, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Ne

2017
[A case of diffusely infiltrating rectal cancer with pulmonary lymphangitis carcinomatosa successfully treated with mFOLFOX6 chemotherapy as salvage].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Fluorouracil; Humans

2008
Fatal pneumonitis induced by oxaliplatin.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:11

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protoc

2008
[Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; L

2009
Interstitial lung disease associated with oxaliplatin: description of two cases.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Adrenal Cortex Hormones; Aged; Antineoplastic Agents; Antineoplastic Combined Chemot

2009
Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).
    International journal of clinical oncology, 2009, Volume: 14, Issue:5

    Topics: Adrenal Cortex Hormones; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic

2009
[A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:13

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites,

2009
Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colore

2010
Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:7

    Topics: Acute Disease; Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti

2010
[Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 55, Issue:5

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; F

2010
Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:4

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alveolitis, Extrinsic Allergic; Antibodies, Monoclona

2011
[Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap

2012
Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
    Journal of gastroenterology, 2004, Volume: 39, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Fatal Outcome; Fluorourac

2004
[A case of sclerosing cholangitis trigered by 5-FU/leucovorine combination therapy and rapidly deteriorated].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangitis, Sclerosing; Colonic Neoplasms; Co

2005
Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, Volume: 7, Issue:11

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Chemothera

2005
Pulmonary toxicity of 5-fluoracil and oxaliplatin.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Lung Diseases, Interstit

2006
Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2006, Volume: 10, Issue:10

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P

2006
[Severe interstitial pneumopathy due to herpes virus after radiochemotherapy for esophageal carcinoma].
    Bulletin du cancer, 2001, Volume: 88, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined

2001